FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1765-1766 June 3, 1999 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Spontaneous clearance of hepatitis B surface antigen (HBsAg) has been reported in about 5 percent of immunocompetent patients with chronic hepatitis B, but not in patients infected with human immunodeficiency virus (HIV).¹ We describe an HIV-infected patient in whom treatment with the HIV-protease inhibitor ritonavir was associated with a flare of his chronic hepatitis B, followed by clearance of the virus and normalization of liver-enzyme levels.

Chronic hepatitis B was diagnosed in 1990 in a 35-year-old asymptomatic HIV-infected patient with a CD4 lymphocyte count of 436x10⁶ cells per liter. The principal laboratory findings during clinical . . . [Full Text of this Article]

References

This article has been cited by other articles:

• DeSimone, J. A., Pomerantz, R. J., Babinchak, T. J. (2000). Inflammatory Reactions in HIV-1-Infected Persons after Initiation of Highly Active Antiretroviral Therapy. ANN INTERN MED 133: 447-454 [Abstract] [Full Text]  
• Velasco, M., Guijarro, C., Sulkowski, M. S., Thomas, D. L., Chaisson, R. E., Moore, R. D. (2000). Elevated Liver Enzymes Following Initiation of Antiretroviral Therapy. JAMA 283: 2526-2527 [Full Text]